Groundbreaking new research was unveiled at the Tampa Convention Center during The Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Two studies found that combining immunotherapy with chemotherapy could lead patients with advanced endometrial cancer to live longer.
The studies were also simultaneously published in the New England Journal of Medicine while they were being presented at the Tampa Convention Center for the first time. These findings received national attention, including from media outlets such as NBC News.
“I was thrilled with the results of this trial. I was thrilled with the impacts that we anticipate this will have,” Ramez N. Eskander, MD, who led the first trial presented, told SGO.
Reaction to this announcement in Tampa has been circulating on Twitter.
“Such an amazing leap forward in endometrial cancer. Absolutely revolutionary - and such important and mind-blowing results that will impact and help so many of our patients,” tweeted Jharna M. Patel, MD.
About SGO
The SGO Annual Meeting on Women’s Cancer is the premier event for those who treat and care for women with gynecologic cancer. This event has been occurring since 1969. Professionals from around the world gather to discuss the latest science in the field. The event was held at the Tampa Convention Center March 25-28, 2023.